Low doses of chemotherapy to inhibit suppressor T cells.
Berd
D
D
Division of Medical Oncology, Thomas Jefferson University, Philadelphia, Pa. 19107.
D000276:Adjuvants, Immunologic / Q000494:pharmacology / Q000627:therapeutic use*; D001500:BCG Vaccine / Q000627:therapeutic use; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D003851:Deoxyribonucleases / Q000276:immunology; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007111:Immunity, Cellular / Q000187:drug effects; D007167:Immunotherapy; D007428:Intradermal Tests; D008545:Melanoma / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D003012:Microbial Collagenase / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects*
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine; D003520:Cyclophosphamide; D003851:Deoxyribonucleases; D003012:Microbial Collagenase